A 64-year-old patient with silent myocardial ischemia after anterior myocardial infarction was treated with directional coronary atherectomy, balloon angioplasty, and placement of Palmaz-Schatz stent. An unexpanded Palmaz-Schatz stent was retained in the left main coronary artery and was treated suc
Successful redeployment of an unexpanded coronary stent
β Scribed by McGinnity, John G. ;Glazier, James J. ;Spears, J. Richard ;Rogers, Christopher ;Turi, Zoltan G.
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 246 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0098-6569
No coin nor oath required. For personal study only.
β¦ Synopsis
We report on treatment of a patient in whom failure to deploy the distal portion of a Palmaz-Schatz stent occurred but was not recognized. After an unstable course, the patient underwent repeat coronary angiography, at which time the stent was rewired and redilated. Full deployment of the stent with restoration of TIMI grade 3 flow was achieved. The putative cause of the problem, incomplete deployment of the stent because of inadvertent advancement of the stent delivery sheath, should be avoided, and needs to be recognized if it occurs. Crossing and redilating the stent is possible, although technically difficult.
π SIMILAR VOLUMES
Stent loss and failure of retrieval are rare; nevertheless, complications have to be taken into account during percutaneous coronary intervention. Here we report a case of an unexpanded, irretrievable Palmaz-Schatz stent in the proximal right coronary artery near to the ostium and the successful man
Primary intracoronary stenting of a calcified left anterior descending coronary artery stenosis was complicated by within-stent coronary artery rupture and subsequent cardiac tamponade. Despite pericardiocentesis and sealing of the perforation by additional stent placement, subsequent stent thrombos
The in situ or free gastroepiploic artery (GEA) is being used as an arterial conduit for coronary artery bypass surgery (CABG). The recent rapid improvements in stent manufacture, particularly their profile and flexibility, and related equipment, have helped reduce complications of coronary angiopla